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Background: Helicobacter pylori has now been widely recognized as a causative agent of gastroduodenal diseases. The 
development of safer anti- H. pylori compounds is desirable due to the antibiotic-resistant strains emerged to date.  
Methods: We successfully developed the compounds of Rice-fluid derived from unpolished, polished, and usually 
cooked Japanese rice, and investigated their in vitro antibacterial activities by means of the Time-Kill-Curve methods 
against various species of bacteria including H. pylori strains. 
Results: All of the compounds revealed keen bactericidal activities against H. pylori, followed by Streptococcus 
pneumoniae and Campylobacter jejuni strains, but failed to affect the viability of other bacterial species investigated 
including staphylococci, enterococci, Pseudomonas aeruginosa, and other gram-negative rods belonging to the family 
Enterobacteraceae. The bactericidal activities were demonstrated to be time- and concentration-dependent.  
Conclusions: The compounds of Rice-fluid are considered to be potentially new and safe therapeutic regimens against 
H. pylori infections. The mechanism of their bactericidal activities against H. pylori strains remains to be elucidated. 
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1.  Introduction 
 Helicobacter pylori is a gram-negative, helical rod 
that colonizes human gastric mucous layer and mucous 
gel layer [1-3]. In humans, infection of H. pylori has been 
regarded as a major cause of chronic gastritis and peptic 
ulcer, and is important in the pathogenesis of gastric 
cancer and gastric mucosa-associated lymphoid tissue 
(MALToma) [4-7]. The eradication of H. pylori can, 
therefore, contribute to the treatment and prevention of 
these diseases. H. pylori eradication accelerates peptic 
ulcer healing [8], reduces the recurrence of gastric cancer 
after resection [9], and leads to regression of low-grade 
gastric MALToma [10]. Currently, new triple therapies 
consisting of two antibiotics and a proton pump inhibitor 
actually demonstrate high eradication rates. However, 
some problems remain. H. pylori rapidly acquire 
resistance to some antibiotics. Indeed, H. pylori strains 
resistant to clarithromycin and metronidazole have been 
increasing [11-18]. In the near future, antibiotic resistance 
will be the utmost impediment in the chemotherapy of H. 
pylori infection. In addition, new triple therapies 
occasionally cause side effects; nausea, vomiting, 
epigastric pain, abdominal discomfort, or diarrhea [19]. 
Therefore, a search of some new antibacterial agent, both 
highly effective and safe, and preferably proves only 
active against H. pylori strains, is desirable for the 
treatment of H. pylori infection. 
Some investigators have documented that various 
medicinal plant extracts confirm antibacterial activities 
[20-24].    We investigated the in vitro antibacterial 
activity of hitherto undescribed compounds of our 
successfully developed Rice-fluid derived from Japanese 
unpolished and polished Japanese raw rice, against a 
variety of bacterial species commonly encountered in 
human infections, including H. pylori strains. 
2.  Materials and Methods 
Bacterial strains 
In this study, two standard strains, that is 
ATCC4350 (type strain) and ATCC43526, and 14 clinical 
isolates of H. pylori (H-1 to H-14) were used. The clinical 
isolates had been obtained from patients at Shinshu 
University Hospital, Matsumoto, 390-8621, Japan. Their 
isolation and identification had been carried out as 
described previously [13, 15]. Five strains, respectively, of 
Staphylococcus aureus,  Staphylococcus epidermidis, 
Streptococcus pneumoniae,  Enterococcus faecalis,  Escherichia 
coli, Pseudomonas aeruginosa, and three strains of Klebsiella 
pneumoniae and two strains of Klebsiella oxytoca were also 
investigated for the antibacterial evaluation study. They 
were all the clinical isolates from patients at Shinshu 
University Hospital, Matsumoto 390-8621, Japan. They 
were all stored in Micro-Bank vials (Pro-Lab Diagnostic, 
Ontario, Canada) at -83°C in a deep  freezer, after 
identification by Vitek II (bioMerieux Japan Ltd., Tokyo, 
Japan) system and/or MicroScan WalkAway (Dade 
Behring Inc., Illinois USA) system. In addition, five 
clinical strains of Campylobacter jejuni were also included 
in this evaluation study, which were the kind gift from Int. J. Med. Sci. 2006, 3   113
Miroku Medical Laboratory, Saku, Nagano 384-2201, 
Japan. Prior to the investigation, H. pylori, S. pneumoniae 
and  C. jejuni strains were grown on Sheep Blood agar 
(Nippon Becton Dickinson Ltd., Tokyo, Japan) plates at 
37°C for 2 days in a microaerophilic atmosphere. In 
addition,  S. aureus,  S. epidermidis,  E. faecalis,  E. coli,  K. 
pneumoniae,  K. oxytoca and P. aeruginosa strains were 
cultured overnight on Heart Infusion agar plates (Eiken 
Chemical Co., Osaka, Japan) in the atmosphere at 37°C, 
and were used for this study. 
Manufacturing design of the Rice-fluid 
We successfully developed the compound of Rice-
fluid derived from Japanese raw rice. Manufacturing of 
the Rice-fluid was conducted in five phases. Phase 1 
involved the addition of 2 to 20-times volume of distilled 
water to either of the two kinds of raw Japanese rice, such 
as unpolished or polished rice. Phase 2 involved their 
incubation at 100 to 190°C under the pressure of 0.01 to 
0.8MPa for 60min. In phase 3, they were completely 
mixed by homogenizing, and were cooled down to 40 to 
55°C. In phase 4, they were treated for 10 to 120min., with 
addition of some amount of proteinase and amylase 
complex including α-amylase,  β-amylase, and gluco-
amylase. In the last phase 5, the enzymes added were 
inactivated by heating the mixture up to 95°C. These 
Rice-fluids, however, have recently been adopted to 
several kinds of liquid food as the main supplemental 
ingredient, and have been commercially available all over 
Japan. In this experiment, the four test compounds were 
investigated for the bactericidal activities, consisting of 
three kinds of Rice-fluid derived from the two kinds of 
raw rice; i. e., polished (pH6.32) and unpolished (pH5.98), 
and the usually cocked rice (pH5.91), and remaining one 
compound of the fluid of usually cocked rice itself 
(pH5.68) which was neither treated with any kind of 
enzyme nor unheated under the high pressure. 
Bactericidal activity 
Bactericidal activities were determined by using an 
in vitro time killing assay [14, 16]. A bacterial suspension 
of 16 H. pylori strains (100μl, approximately 108CFU/ml) 
was inoculated into 1ml of a Rice-fluid, a ten-fold-
dilution Rice-fluid and a pH-adjusted (to the pH of 
respective Rice-fluid) physiological saline solution, 
respectively. The cultures were incubated with gentle 
shaking at 37°C in a microaerophilic atmosphere. 
Samples (100μl) for viability measurement were taken at 
various points of time, that is, 30min., 60min., and 
120min., respectively. Viability was determined by the 
plate colony count technique. After serial 10-fold dilution 
technique with saline solution, 100μl of each sample was 
plated onto Sheep Blood agar plates. Appearing colonies 
were counted after 3 days of incubation at 37°C in a 
microaerophilic atmosphere. The remaining bacterial 
species were also determined in almost the same manner 
as in the case of H. pylori strains described above. Heart 
Infusion agar plates (Eiken Chemical Co., Osaka, Japan) 
were used instead of Sheep Blood agar plates (Nippon 
Becton Dickinson Ltd., Tokyo, Japan), and incubation was 
performed at 37°C under ambient air. 
Effect on the morphology of H. pylori cells 
H. pylori ATCC43526 strain was inoculated into 1ml 
of the Rice-fluid. After exposing to the Rice-fluid at 37°C 
in a microaerophilic atmosphere, an aliquot of the sample 
for morphological study was taken at various times, then 
fixed with ethyl alcohol solution and Gram-stained H. 
pylori cells were observed microscopically (×1,000; 
Olympus, Tokyo, Japan). 
3.  Results 
Bactericidal Activities against H. pylori, C. jejuni, and S. 
pneumoniae 
Fig. 1 is the killing kinetics of various kinds of Rice-
fluid against H. pylori ATCC43526 strain. Among them, 
both the Rice-fluids derived from unpolished and 
polished Japanese raw rice revealed remarkably strong 
bactericidal activities, and followed by the Rice-fluid 
derived from usually cooked Japanese rice. The number 
of viable H. pylori cells decreased progressively by 
exposure to the Rice-fluid and reached less than the assay 
limit within 60min. Nearly the same bactericidal activities 
were demonstrated against respective 5 strains of both S. 
pneumoniae and C. jejuni (data, not shown.). On the other 
hand, usually cooked Japanese rice itself and the pH-
adjusted physiological saline solution demonstrated no 
bactericidal activities against H. pylori ATCC43526 strain. 
The remaining ATCC43504 type strain and 14 clinical H. 
pylori strains (H-1 to H-14) simultaneously tested showed 
almost exactly the same results with those of H. pylori 
ATCC43526 strain.  
Fig. 2 illustrated the bactericidal activities of the 
undiluted and ten-fold diluted Rice-fluid derived from 
unpolished Japanese raw rice against H. pylori strains. 
The Rice-fluid derived from un-polished Japanese raw 
rice, as shown in Fig. 2, revealed time- and concentration- 
dependent bactericidal activities, which was also the case 
with the Rice-fluid derived from polished Japanese raw 
rice. 
Bactericidal Activity against strains other than H. pylori, 
C. jejuni, and S. pneumoniae 
Any kind of Rice-fluid demonstrated to be lacking in 
bactericidal activity against E. coli E1 strain, as shown in 
Fig. 3. Almost exactly the same phenomena were 
observed against other four strains of E. coli, five strains 
of S. aureus, S. epidermidis, E. faecalis and P. aeruginosa, and 
three strains of K. pneumoniae and two strains of K. oxytoca, 
respectively (data not shown). 
Effect on Morphology of H. pylori 
The results of morphological study are shown in Fig. 
4. H. pylori cells aggregated with each other and formed 
clusters (Fig. 4) by exposure to the Rice-fluid derived 
from unpolished Japanese raw rice. 
4.  Discussion 
We investigated the in vitro antimicrobial activities 
of the three kinds of Rice-fluid against various species of 
microorganisms including H. pylori strains by the time-
kill-curve assay [14, 16]. Every kind of Rice-fluid derived 
from unpolished and polished raw rice, and from usually 
cooked Japanese rice demonstrated strong bactericidal 
activities only against H. pylori,  S. pneumoniae and C. 
jejuni strains. Among the three species described above, 
the compounds revealed strikingly strong activities 
against H. pylori strains as demonstrated in Figs. 1 and 2. 
Among the three compounds, bactericidal activities of the 
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were less active than those of the two kinds of Rice-fluid 
derived from unpolished and polished Japanese raw rice. 
However, other compounds such as usually cooked 
Japanese rice itself together with pH-adjusted 
physiological saline solution revealed no antibacterial 
activity against the microorganisms examined, as shown 
in Fig. 1. Moreover, it should be noted that any kind of 
Rice-fluid was proved to be devoid of bactericidal activity 
against 5 strains of E. coli,  S. aureus, S. epidermidis,  E. 
faecalis and P. aeruginosa, and 3 strains of K. pneumoniae 
and 2 strains of K. oxytoca, respectively. The 
representative case of E. coli E1 isolate was shown in Fig. 
3. 
It is noteworthy that the bactericidal activity was 
demonstrated only against the restricted bacterial species 
such as H. pylori, C. jejuni and S. pneumoniae, which were 
known to grow well under microaerophilic atmosphere. 
The most interesting findings are that the bactericidal 
spectrum of the ‘Japanese rice-fluid’ is rather narrow. In 
fact, the bactericidal activities were expressed against 
only the restricted bacterial species sharing with the 
common properties that their growths are dependent on 
and/or enhanced under strengthened CO2 gas conditions. 
On the other hand, the emergence of antibiotic 
resistant  H. pylori strains has been increasing and the 
problems for the chemotherapy have also been growing. 
The new and safer anti-H. pylori agents with high 
selective toxicity are urgently desirable. As mentioned 
above, it should be noted that no compounds examined 
in this study demonstrated antibacterial activity against E. 
coli,  K. pneumoniae,  K. oxytoca,  E. faecalis, the 
representative well known normal inhabitants of human 
intestinal flora. Provided that the new agent had been 
determined and isolated from the Rice-fluid, and had 
become available for clinical use, it would be 
outstandingly favorable against H. pylori infections for 
not interfering the normal bacterial flora in the intestine 
of humans. Moreover, it should also be advantageous 
that the compounds of Rice-fluid failed to affect the 
survival of S. aureus,  S. epidermidis, and P. aeruginosa, 
demonstrating that the antibacterial spectrum of the Rice-
fluid was extremely narrow and only active against the 
restricted organisms.  
Thus, these findings imply that the compounds of 
Rice-fluid derived from Japanese raw rice possibly 
contain bactericidal agents demonstrating to have 
potentials as new therapeutic agents against H. pylori 
infection. The mechanisms in detail of bactericidal 
activity against the three species, especially H. pylori 
strains remain to be elucidated. 
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Figures 
Figure 1.  Bactericidal activity of each compound against Helicobacter pylori ATCC43526 strain. H. pylori ATCC43526 strain 
was exposed to Rice-fluid derived from unpolished Japanese rice (■), from polished Japanese rice (▲), from usually cooked 
Japanese rice (□), usually cooked rice itself (△) and to pH-adjusted physiological saline solution (×) as a control. Samples were 
taken at the time indicated, and viability was determined by the plate colony count procedure. 
 
Figure 2.  Bactericidal activity of Rice-fluid derived from unpolished Japanese rice against Helicobacter pylori strains. H. pylori 
strain was exposed to undiluted Rice-fluid from unpolished Japanese rice (●), to ten-fold diluted Rice-fluid (△) and to pH-
adjusted physiological saline solution (×) as a control. Samples were taken at the time indicated, and viability was determined by 
the plate colony count procedure.  
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Figure 3.  Bactericidal activity of Rice-fluid derived from unpolished Japanese rice against clinical Escherichia coli E1 isolate. 
Clinical E. coli E1 isolate was exposed to Rice-fluid derived from unpolished Japanese rice (●), from ten-fold dilution Rice-fluid 
(△) and to pH-adjusted physiological saline solution (×) as a control. Samples were taken at the time indicated, and viability was 
determined by the plate colony count procedure.  
 
Figure 4.  Effect of Rice-fluid derived from unpolished Japanese rice on the morphology of Helicobacter pylori ATCC43504 cells. 
H. pylori ATCC43504 strain was exposed to Rice-fluid derived from unpolished Japanese rice. Samples were taken at the time 
indicated and gram-stained H. pylori cells were observed microscopically (×1,000; Olympus, Tokyo, Japan.). 
  